- Home
- OSIS vs VKTX Comparison
OSIS vs VKTX Comparison
Compare OSIS & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSIS
- VKTX
- Stock Information
- Founded
- OSIS 1987
- VKTX 2012
- Country
- OSIS United States
- VKTX United States
- Employees
- OSIS N/A
- VKTX N/A
- Industry
- OSIS Industrial Machinery/Components
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- OSIS Technology
- VKTX Health Care
- Exchange
- OSIS Nasdaq
- VKTX Nasdaq
- Market Cap
- OSIS 3.9B
- VKTX 3.5B
- IPO Year
- OSIS 1997
- VKTX 2015
- Fundamental
- Price
- OSIS $234.84
- VKTX $25.53
- Analyst Decision
- OSIS Strong Buy
- VKTX Strong Buy
- Analyst Count
- OSIS 6
- VKTX 13
- Target Price
- OSIS $229.17
- VKTX $86.92
- AVG Volume (30 Days)
- OSIS 204.9K
- VKTX 9.7M
- Earning Date
- OSIS 10-23-2025
- VKTX 10-22-2025
- Dividend Yield
- OSIS N/A
- VKTX N/A
- EPS Growth
- OSIS 18.02
- VKTX N/A
- EPS
- OSIS 8.71
- VKTX N/A
- Revenue
- OSIS $1,713,166,000.00
- VKTX N/A
- Revenue This Year
- OSIS $6.70
- VKTX N/A
- Revenue Next Year
- OSIS $5.42
- VKTX N/A
- P/E Ratio
- OSIS $27.06
- VKTX N/A
- Revenue Growth
- OSIS 11.33
- VKTX N/A
- 52 Week Low
- OSIS $129.84
- VKTX $18.92
- 52 Week High
- OSIS $241.64
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- OSIS 55.78
- VKTX 38.76
- Support Level
- OSIS $226.00
- VKTX $24.82
- Resistance Level
- OSIS $240.71
- VKTX $26.50
- Average True Range (ATR)
- OSIS 5.96
- VKTX 1.25
- MACD
- OSIS 0.44
- VKTX -0.10
- Stochastic Oscillator
- OSIS 65.86
- VKTX 24.64
About OSIS OSI Systems Inc. (DE)
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.